Matches in SemOpenAlex for { <https://semopenalex.org/work/W2515692276> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2515692276 endingPage "1" @default.
- W2515692276 startingPage "1" @default.
- W2515692276 abstract "To examine the relevance of concentration of benzalkonium chloride (BAK) on the cornea, we investigated the effects of latanoprost containing BAK alone and in combination with other antiglaucoma drug classes on corneal epithelium in vitro in a cultured rabbit corneal cell line (SIRC) and in vivo, using a corneal resistance device (CRD). [In vitro] staten's seruminstitut rabbit corneal cells were exposed to 0.005% latanoprost for 30 s, followed by either phosphate buffered saline (control), 0.1% brimonidine, 0.5% timolol, 1% dorzolamide, or 1% brinzolamide. The number of viable cells was counted at 8, 15, and 30 min. [In vivo] Albino rabbits were administered one drop of 0.005% latanoprost, followed 5 min later by one drop of an agent from the in vitro trial. This was repeated every 15 min for a total of three times. The change in corneal barrier function was assessed by measuring the corneal resistance at 2 and 30 min after the final administration. [In vitro] At 8 min, the viable cell count in the latanoprost+dorzolamide group was significantly lower than in the control group. At 15 and 30 min, all treatment groups, except the latanoprost+brimonidine group, demonstrated significantly lower viable cell counts than the control group. [In vivo] At 2 min after the final eye drop, the latanoprost+timolol group and the latanoprost+brinzolamide group demonstrated significantly lower corneal resistance than did the latanoprost+brimonidine group. No significant difference was observed between the agents at 30 min. In conclusion, when combining latanoprost containing benzalkonium chloride with other classes of antiglaucoma drugs, brimonidine may cause the least corneal damage, and the number of drug administrations may be an important factor." @default.
- W2515692276 created "2016-09-16" @default.
- W2515692276 creator A5069778276 @default.
- W2515692276 creator A5078620103 @default.
- W2515692276 date "2016-09-01" @default.
- W2515692276 modified "2023-09-25" @default.
- W2515692276 title "Ocular pharmacology: Cinderella becomes the queen" @default.
- W2515692276 doi "https://doi.org/10.1016/j.ejphar.2016.08.016" @default.
- W2515692276 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27596022" @default.
- W2515692276 hasPublicationYear "2016" @default.
- W2515692276 type Work @default.
- W2515692276 sameAs 2515692276 @default.
- W2515692276 citedByCount "0" @default.
- W2515692276 crossrefType "journal-article" @default.
- W2515692276 hasAuthorship W2515692276A5069778276 @default.
- W2515692276 hasAuthorship W2515692276A5078620103 @default.
- W2515692276 hasConcept C118487528 @default.
- W2515692276 hasConcept C150903083 @default.
- W2515692276 hasConcept C185592680 @default.
- W2515692276 hasConcept C207001950 @default.
- W2515692276 hasConcept C2775919038 @default.
- W2515692276 hasConcept C2776727336 @default.
- W2515692276 hasConcept C2776740260 @default.
- W2515692276 hasConcept C2776882836 @default.
- W2515692276 hasConcept C2777397205 @default.
- W2515692276 hasConcept C2777625524 @default.
- W2515692276 hasConcept C2778073030 @default.
- W2515692276 hasConcept C2778190193 @default.
- W2515692276 hasConcept C2780276452 @default.
- W2515692276 hasConcept C2781092963 @default.
- W2515692276 hasConcept C42219234 @default.
- W2515692276 hasConcept C43617362 @default.
- W2515692276 hasConcept C71924100 @default.
- W2515692276 hasConcept C86803240 @default.
- W2515692276 hasConcept C98274493 @default.
- W2515692276 hasConceptScore W2515692276C118487528 @default.
- W2515692276 hasConceptScore W2515692276C150903083 @default.
- W2515692276 hasConceptScore W2515692276C185592680 @default.
- W2515692276 hasConceptScore W2515692276C207001950 @default.
- W2515692276 hasConceptScore W2515692276C2775919038 @default.
- W2515692276 hasConceptScore W2515692276C2776727336 @default.
- W2515692276 hasConceptScore W2515692276C2776740260 @default.
- W2515692276 hasConceptScore W2515692276C2776882836 @default.
- W2515692276 hasConceptScore W2515692276C2777397205 @default.
- W2515692276 hasConceptScore W2515692276C2777625524 @default.
- W2515692276 hasConceptScore W2515692276C2778073030 @default.
- W2515692276 hasConceptScore W2515692276C2778190193 @default.
- W2515692276 hasConceptScore W2515692276C2780276452 @default.
- W2515692276 hasConceptScore W2515692276C2781092963 @default.
- W2515692276 hasConceptScore W2515692276C42219234 @default.
- W2515692276 hasConceptScore W2515692276C43617362 @default.
- W2515692276 hasConceptScore W2515692276C71924100 @default.
- W2515692276 hasConceptScore W2515692276C86803240 @default.
- W2515692276 hasConceptScore W2515692276C98274493 @default.
- W2515692276 hasLocation W25156922761 @default.
- W2515692276 hasLocation W25156922762 @default.
- W2515692276 hasOpenAccess W2515692276 @default.
- W2515692276 hasPrimaryLocation W25156922761 @default.
- W2515692276 hasRelatedWork W1988307533 @default.
- W2515692276 hasRelatedWork W2054254645 @default.
- W2515692276 hasRelatedWork W2098532635 @default.
- W2515692276 hasRelatedWork W2106674716 @default.
- W2515692276 hasRelatedWork W2383719445 @default.
- W2515692276 hasRelatedWork W3037975320 @default.
- W2515692276 hasRelatedWork W3119585194 @default.
- W2515692276 hasRelatedWork W3182592653 @default.
- W2515692276 hasRelatedWork W4210241396 @default.
- W2515692276 hasRelatedWork W2177385783 @default.
- W2515692276 hasVolume "787" @default.
- W2515692276 isParatext "false" @default.
- W2515692276 isRetracted "false" @default.
- W2515692276 magId "2515692276" @default.
- W2515692276 workType "article" @default.